Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare, but serious, genetic disorder that causes abnormal blood vessels to form throughout the body. These abnormal vessels bypass much smaller blood vessels, or capillaries, creating direct connections between arteries and veins known as arteriovenous malformations (AVMs). This can lead to serious health issues, including internal bleeding and complications in vital organs like the lungs, brain, spine, liver and gastrointestinal tract.

The Mary Heersink Institute for Global Health is excited to announce the second cohort of pilot grant awardees.